Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
MALACHITE: PfSPZ Immunization Under Atovaquone/Proguanil Chemoprophylaxis
NCT02858817Phase 1Completed
- Sponsor
- University Hospital Tübingen
- Start
- Nov 2016
- Primary completion
- Nov 2017
- Modality
- Live Biotherapeutic Products, Vaccines & Immunotherapeutics
01
Overview
Phase 1, randomised, double-blind trial of PfSPZ Challenge in malaria (3 arms), sponsored by University Hospital Tübingen. Primary endpoint: Number or occurrence of related Grade 3 and 4 adverse events and serious adverse events at 414 days. Started Nov 2016; status: completed.
02
Drugs
PfSPZ Challenge
03
Conditions
malaria
Beyond the preview
Go deeper on NCT02858817.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT02858817.